Oakworth Capital Inc. Acquires 880 Shares of Thermo Fisher Scientific Inc. (TMO)
Oakworth Capital Inc. lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 332.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,145 shares of the medical research company’s stock after buying an additional 880 shares during the period. Oakworth Capital Inc.’s holdings in Thermo Fisher Scientific were worth $214,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Amalgamated Bank grew its position in shares of Thermo Fisher Scientific by 57.0% during the 2nd quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock valued at $7,837,000 after buying an additional 16,308 shares during the last quarter. Mutual of America Capital Management LLC boosted its stake in Thermo Fisher Scientific by 2.1% during the 2nd quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock valued at $8,327,000 after purchasing an additional 977 shares during the period. Mitchell Capital Management Co. boosted its stake in Thermo Fisher Scientific by 40.3% during the 2nd quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock valued at $7,841,000 after purchasing an additional 12,910 shares during the period. State Board of Administration of Florida Retirement System boosted its stake in Thermo Fisher Scientific by 0.9% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock valued at $101,317,000 after purchasing an additional 5,213 shares during the period. Finally, San Francisco Sentry Investment Group CA acquired a new position in Thermo Fisher Scientific during the 2nd quarter valued at about $1,451,000. 86.16% of the stock is owned by institutional investors and hedge funds.
Shares of Thermo Fisher Scientific Inc. (TMO) traded up $2.33 during trading hours on Monday, hitting $187.96. 2,437,700 shares of the stock were exchanged, compared to its average volume of 1,564,998. The firm has a market cap of $75,371.09, a price-to-earnings ratio of 20.66, a P/E/G ratio of 1.72 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 12 month low of $139.88 and a 12 month high of $201.20. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business’s revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period in the prior year, the business posted $2.03 EPS. equities analysts forecast that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.
In related news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares in the company, valued at approximately $47,582,981.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.49% of the stock is owned by insiders.
A number of research analysts have issued reports on TMO shares. Cowen reissued a “buy” rating and set a $200.00 target price on shares of Thermo Fisher Scientific in a research note on Friday, September 1st. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research note on Thursday, September 7th. Goldman Sachs Group started coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price for the company. Finally, Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Thursday, October 26th. One investment analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific presently has an average rating of “Buy” and an average target price of $205.21.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/oakworth-capital-inc-acquires-880-shares-of-thermo-fisher-scientific-inc-tmo/1757734.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.